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Phidianidines are a class of compound that has been extracted from the sea mollusk Phidianis militaris. These compounds have been 
shown to exhibit a variety of useful properties such as antihistamine effects, anti-cancer activity, agonism of the µ-opioid receptor and 
neuroprotection. The biological activities are thought to be caused by the 1,2,4- oxadiazole ring found within the molecule. The goal of 
this project is to synthesize analogues of phidianidine that contain a 1,2,3-triazole instead of the 1,2,4 oxadiazole ring using a method 
that will allow for other regions of the molecule to be changed. This will help to elucidate the role of the 1,2,4-oxadiazole ring in 
biological activity as well as probe if the 1,2,3-triazole analogue can provide significant improvement to any activities. 
Introduction 
 
Marine organisms have been proven a rich source for bioactive 
molecules over the last 50 years. Many of the marine natural products 
discovered belong to a class of compounds called alkaloids.1-3 Alkaloids 
are produced widely by both terrestrial and marine organisms and 
evolved as a defense mechanism. For this reason alkaloids are often 
cytotoxic. A subset of alkaloids, indole alkaloids, are important 
compounds in the field of drug discovery that commonly possess 
neurological activity.4,5 One such group of indole alkaloids are the 
phidianidines, which were isolated by Gavagnin in 2011 from the sea 
mollusk Phidianis militaris. Phidianidines A and B (Figure 1), which 
differ based on the presence of a bromide, possess a unique 1,2,4-
oxadizole ring and biological properties.6  
 The phidianidines have a range of interesting bioactivity such as 
anticancer6, HIV and neurological activity.7,8 Phidianidine A binds to the 
chemokine receptor CXCR4. CXCR4 is an important target in the field 
of pharmacology due to its involvement in HIV progression, tumor 
development and metastasis, and rheumatoid arthritis. Phidianidine A 
was shown to bind to CXCR4 moderately with hopes of improving its 
activity.7 Additionally; the phidianidines have interesting applications in 
neurological disorders. They function as a selective inhibitor of the 
dopamine transporter and a selective ligand of the µ-opioid receptor.8 
Selectivity among opioid receptors is important because the δ- and κ- 
opioid receptors are linked to addiction, while the µ-opioid receptor is 
responsible for the analgesic effects.9,10 Other projects investigated the 
neuroprotective activities of phidianidine derivatives, and found that 4-
substituted phidianidine derivatives offer significant protection against 
hydrogen peroxide and oxygen-glucose deprivation in vitro which can 
impact the onset and progression of neurodegenerative diseases like 
Alzhiemer’s.11 Given these several important biological activities, 
synthesis of phidianidine analogues are essential to understanding and 
improving its functions. 
 Phidianidines are composed of three distinct regions, an indole, a 
1,2,4-oxadiazole ring, and an aminoalkylguanidine chain. The bioactivity 
is mainly thought to be a result of the 1,2,4-oxadiazole ring, and 
phidianidine is the first isolated natural product to contain this structure.6  
Previous synthesis of the phidianidines used a hydroxyguanidine linker 
with a protected nitrogen and ethyl indole-3-acetate to form the 1,2,4-
oxadiazole ring.12,13 This has limited the ability of groups to explore the 
affect of structural changes to the 1,2,4-oxadiazole and indole on the 
biological activity. We hope to develop an approach to phidianidine 
analogues that addresses this limitation. 
 The overall goal of this project is to synthesize a 1,2,3-triazole 
analogue of the phidianidines (Figure 2) via cyclization of an azido-
group with a 3-propargyl indole.14 This approach will allow for the 
impact of changes to the 1,2,4-oxadiazole ring and indole on the 
molecule’s biological activity to be determined.  The identification of 
cyclization conditions to be used for the synthesis of the 1,2,3-triazole 
analogues is reported herein.   
 
Chemistry 
In the reaction scheme, indole was reacted with propargyl bromide to 
produce 3-propargyl indole (Scheme 1). This reaction was successfully 
realized with a variety of indoles (Table 1). To determine the optimum 
conditions for the synthesis of the 1,2,3-triazole heterocycle, 
Figure 1. Structure of phidianidine A and B 
Figure 2. The key step to the 1,2,3-triazole analogues of the 
phidianidines 
Scheme 1. Synthesis of 3-propargyl indoles 
 
 
Table 1. Results of 3-propargyl indole syntheses 
 
 
Entry R Yield 
1 H 84% 
2 2-methyl 43% 
3 4-methyl 96% 
4 6-bromo 87% 
5 7-methyl 86% 
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commercially available benzyl azide was used as a model (Scheme 2). 
Treatment of the alkyne and azide under standard cycloaddition 
conditions gave poor results15 (Table 2, entry 1).  No product was 
isolated though this could be due to difficulties in purification.  In order 
to improve the yield, the equivalents of the reactants were doubled and 
the temperature increased to 60˚C. This provided moderate increases to 
yield in some cases, however the yield was still around 30% (Table 2, 
entries 2-4). The temperature and equivalents were increased again 
(80˚C, 4 equiv.) however the yield decreased to 8% (Table 2, entry 5). It 
was hypothesized that the low yields were caused by oxidation of the Cu 
(I) catalyst by O2 gas within the solvent. The solvent was degassed with 
bubbling N2; this led to the heterocycle being successfully synthesized in 
59% yield (Table 2, entry 6). The cyclization was also tested with 
various indoles with less success (Table 2, entries 7-10). Using benzyl 
azide for the reaction allowed for reaction conditions to be developed, 
but provided a truncated analogue of the natural product missing the 
guanidine functionality. Work is currently underway to identify more 
general cyclization conditions and to construct the azide needed to 
synthesize the full analogue. 
Methods 
 
General Procedure for the synthesis of 3-propargyl indoles 
A solution of 3.0 M MeMgI in ether (1.1 equiv) was added to benzene 
and heated to 40 ˚C.  To this solution was slowly added the appropriate 
indole in 2 mL benzene. After 10 min, propargyl bromide (0.7 equiv) 
was added. The reaction stirred overnight at reflux then quenched with 
NH4Cl, extracted with EtOAc (2x).  The combined organic layers were 
washed with brine, dried (MgSO4), filtered and concentrated in vacuo.
16 
 
3-propargylindole 
After completing the general procedure with 20 mL of benzene and 20 
mmol of indole, the residue was purified via flash chromatography on 
SiO2 (1:9, EtOAc:Hexanes) to yield 1.72 g (84%) as a red-brown oil. 
1H 
NMR (400 MHz, CDCl3) δ 8.04 (bs, 1 H), 7.66 (d, 1 H, J = 8.0 Hz), 7.38 
(d, 1 H, J = 8.0 Hz), 7.25-7.19 (m, 2 H), 7.16 (t, 1H, J = 8.0 Hz), 3.72 (s, 
2 H), 2.17-2.14 (m, 1 H). 
 
3-propargyl-2-methylindole 
After completing the general procedure with 5 mL of benzene and 5 
mmol of 2-methylindole, the residue was purified via flash 
chromatography on SiO2 (1:9, EtOAc:Hexanes) to yield 0.24 g (43%). 
1H NMR (400 MHz, CDCl3) δ 7.82 (bs, 1 H), 7.68 (d, 1 H, J = 8.0 Hz), 
7.24-7.14 (m, 3 H), 3.67 (s, 2 H), 2.47 (s, 3 H), 2.09-2.08 (m, 1 H). 
 
6-bromo-3-propargylindole 
After completing the general procedure with 5 mL of benzene and 5 
mmol of 6-bromoindole, the residue was purified via flash 
chromatography on SiO2 (1:9, EtOAc:Hexanes) to yield 0.66 g (87%) as 
a dark brown solid. 1H NMR (400MHz, CDCl3) δ 8.02 (bs, 1 H), 7.53-
7.49 (m, 2 H), 7.25 (d, 1 H, J = 8.4 Hz), 7.16 (s, 2 H), 2.17-2.14  (m, 1 
H). 
 
3-propargyl-7-methylindole 
After completing the general procedure with 5 mL of benzene and 5 
mmol of 7-methylindole, the residue was purified via flash 
chromatography on SiO2 (1:9, EtOAc:Hexanes) to yield 0.47 g (86%) as 
a brown solid. 1H NMR (400MHz, CDCl3) δ 8.01 (bs, 1 H), 7.59 (d, 1 H, 
J = 7.6 Hz), 7.20-7.08 (m, 3 H), 3.8 (s, 2 H), 2.58 (s, 3 H), 2.24-2.23 (m, 
1 H) . 
 
Synthesis of 1,2,3-triazole with benzyl azide  
To a mixture of 3-propargyl indole (50 mg, 0.30 mmol) in 4 mL of H2O: 
tBuOH: DCM (2:2:1) was added benzyl azide (0.04 mL, 0.33 mmol) and 
CuSO4 (7 mg, 0.04 mmol). The reaction was then degassed via bubbling 
N2 for 30 min. The reaction was then treated with sodium ascorbate (26 
mg, 0.13 mmol) and stirred overnight. The organic was extracted with 
DCM (3x), washed with brine, dried (MgSO4), filtered and concentrated 
in vacuo.15 The residue was purified via chromatography on SiO2 (1:9 to 
4:6 EtOAc:Hexanes) to yield 25 mg (59%) of an orange-brown oil. 1H 
NMR (400MHz, CDCl3) δ 8.05 (bs, 1 H), 7.51 (d, 1 H, 7.6 Hz), 7.39-
7.29 (m, 4 H), 7.24-7.16 (m, 3 H), 7.15-7.05 (m, 3 H), 5.45 (s, 2 H), 4.23 
(s, 2 H). 
 
Results and Conclusion  
 
The initial steps toward the synthesis of 1,2,3-triazole analogues of 
phidianidine have been realized.  Addition of propargyl to the 3-position 
of indole has been achieved with variety of indoles, with yields between 
80-90%. This opens a route for a variety of 1,2,3-triazole analogues to 
be synthesized from various indoles. Synthesis of the 1,2,3-triazole 
heterocycle was realized with 59% yield though more work is needed to 
expand the substrate scope. In addition to this, the synthesis of an azide 
that will yield guanidine side chain is ongoing.  
Scheme 2. Synthesis of the 1,2,3-triazole ring 
Table 2. Optimization of the cycloaddition reaction
 
Entry R Benzyl Azide 
equiv. 
Sodium 
Ascorbate 
equiv. 
CuSO4 
equiv. Temp Yield 
1 H 1.1 0.45 0.15 RT ---------- 
2 H 2.2 0.9 0.3 60˚C 31% 
3 H 2.2 0.9 0.3 60˚C 35% 
4 H 2.2 0.9 0.3 60˚C 8% 
5 H 4.4 1.8 0.6 80˚C 28% 
6 H 1.1 0.45 0.15 RT 59% 
7 H 2.2 0.9 0.3 60˚C 8% 
8 6-bromo 1.1 0.45 0.15 RT 17% 
9 7-methyl 1.1 0.45 0.15 RT 25% 
10 2-methyl 1.1 0.45 0.15 RT 14% 
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